Update on vaccination guidelines for allergic children

Expert Review of Vaccines

Volumn 8, Issue 11, 2009, Pages 1541-1546

  Kelso, John M ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

Allergy; Anaphylaxis; Atopy; Immunization; Vaccination

Indexed keywords

ALLERGEN; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; EGG PROTEIN; GELATIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LATEX; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; NEOMYCIN; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; ROTAVIRUS VACCINE; RUBBER; RUBELLA VACCINE; SMALLPOX VACCINE; THIOMERSAL; TRIHIBIT; TYPHOID VACCINE; UNCLASSIFIED DRUG; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATOPIC DERMATITIS; ATOPY; BRADYCARDIA; BRONCHOSPASM; CHILD; CONSCIOUSNESS DISORDER; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DYSPHAGIA; DYSPNEA; ECZEMA; ECZEMA VACCINATUM; EDEMA; EGG; EGG ALLERGY; FLUSHING; HEART PALPITATION; HUMAN; HYGIENE; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNITY; IMMUNIZATION; INFLUENZA VACCINATION; LONG TERM CARE; MUSCLE CRAMP; NAUSEA; PALLOR; PREVALENCE; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; RHINOCONJUNCTIVITIS; SIDE EFFECT; SMALLPOX; SYNCOPE; TACHYCARDIA; TREATMENT CONTRAINDICATION; URTICARIA; VACCINATION; VOICE CHANGE; VOMITING;

CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; FEMALE; HUMANS; HYPERSENSITIVITY; INFANT; MALE; VACCINATION; VACCINES;

EID: 70449396877     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.09.107     Document Type: Review

References (41)

1. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2007. Vital Health Stat. 10(239), 1-80 (2009).
2. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol. 43(4), 649-655 (2000). (Pubitemid 30781516)
3. CDC. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Wolfe S, Hamborsky J, McIntyre L (Eds). Public Health Foundation, Washington DC, USA (2009). • 'The Pink Book' is a practical, up-to-date resource with general recommendations on vaccination as well as chapters on specific vaccine-preventable diseases.
4. CDC. CDC Health Information for International Travel 2010. US Department of Health and Human Services, Public Health Service, Atlanta, GA, USA (2009). • 'The Yellow Book' is a practical, up-to-date resource on all aspects of travel health, not only vaccines, but also malaria prophylaxis, travelers' diarrhea, and so on.
5. CDC. Guide to Vaccine Contraindications and Precautions (2009).
6. Kelso JM. Adverse reactions to vaccines for infectious diseases. In: Middleton's Allergy: Principles & Practice. Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FER (Eds). Mosby, PA, USA, 1189-1204 (2009). • Summary of not only allergic reactions, but also other adverse reactions to vaccines.
7. Bohlke K, Davis RL, Marcy SM et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112(4), 815-820 (2003). (Pubitemid 37248689)
8. Wood RA, Berger M, Dreskin SC et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 122(3), e771-e777 (2008).
9. Kelso JM, Jones RT, Yunginger JW. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. J. Allergy Clin. Immunol. 91(4), 867-872 (1993).
10. Sakaguchi M, Nakayama T, Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J. Allergy Clin. Immunol. 98(6 Pt 1), 1058-1061 (1996).
11. Sakaguchi M, Yamanaka T, Ikeda K et al. IgE-mediated systemic reactions to gelatin included in the varicella vaccine. J. Allergy Clin. Immunol. 99(2), 263-264 (1997).
12. Sakaguchi M, Miyazawa H, Inouye S. Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines. Allergy 56(6), 536-539 (2001). (Pubitemid 32521435)
13. O'Brien TC, Maloney CJ, Tauraso NM. Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion. Appl. Microbiol. 21(4), 780-782 (1971).
14. James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N. Engl. J. Med. 332(19), 1262-1266 (1995).
15. Baxter DN. Measles immunization in children with a history of egg allergy. Vaccine 14(2), 131-134 (1996).
16. Red Book. Report of the Committee on Infectious Diseases. Pickering LK (Ed.). American Academy of Pediatrics, IL, USA (2009). • 'The Red Book' is a practical, concise resource on the diagnosis and treatment of all infectious diseases in children.
17. James JM, Zeiger RS, Lester MR et al. Safe administration of influenza vaccine to patients with egg allergy. J. Pediatr. 133(5), 624-628 (1998).
18. Zeiger RS. Current issues with influenza vaccination in egg allergy. J. Allergy Clin. Immunol. 110(6), 834-840 (2002).
19. Kelso JM. Raw egg allergy - a potential issue in vaccine allergy. J. Allergy Clin. Immunol. 106(5), 990 (2000).
20. DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J; Team VAERS. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 24(6), 703-707 (2006). (Pubitemid 43190077)
21. Gardasil® (Human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant), package insert. Merck & Co., Inc., NJ, USA (2008).
22. Lear JT, English JS. Anaphylaxis after hepatitis B vaccination. Lancet 345(8959), 1249 (1995).
23. Russell M, Pool V, Kelso JM, Tomazic-Jezic VJ. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS). Vaccine 23(5), 664-667 (2004). (Pubitemid 39473196)
24. Kwittken PL, Rosen S, Sweinberg SK. MMR vaccine and neomycin allergy. Am. J. Dis. Child. 147(2), 128-129 (1993).
25. Zheng W, Dreskin SC. Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. Ann. Allergy Asthma Immunol. 99(6), 574-575 (2007). (Pubitemid 350308761)
26. FluMist® (Influenza Virus Vaccine Live, Intranasal), package insert. MedImmune, MD, USA (2008).
27. Bergen R, Black S, Shinefield H et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr. Infect. Dis. J. 23(2), 138-144 (2004). (Pubitemid 38222786)
28. Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356(7), 685-696 (2007). (Pubitemid 46257231)
29. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine 26(Suppl. 4), D10-D16 (2008).
30. Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J. 21(1), 44-48 (2002). (Pubitemid 34073958)
31. Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J. 25(10), 860-869 (2006). (Pubitemid 44510577)
32. Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr. Infect. Dis. J. 27(5), 444-452 (2008).
33. Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm. Rep. 57(RR-7), 1-60 (2008).
34. Wharton M, Strikas RA, Harpaz R et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep. 52(RR-7), 1-16 (2003).
35. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J. Allergy Clin. Immunol. 113(3), 395-400 (2004).
36. Anderson HR, Poloniecki JD, Strachan DP et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am. J. Public Health 91(7), 1126-1129 (2001).
37. Koppen S, de Groot R, Neijens HJ, Nagelkerke N, van Eden W, Rumke HC. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 22(25-26), 3375-3385 (2004).
38. Syncope after vaccination - United States, January 2005-July 2007. MMWR Morb. Mortal. Wkly Rep. 57(17), 457-460 (2008).
39. Bohlke K, Davis RL, DeStefano F et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J. Allergy Clin. Immunol. 113(3), 536-542 (2004). (Pubitemid 38338961)
40. Nakayama T, Aizawa C. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J. Allergy Clin. Immunol. 106(3), 591-592 (2000). (Pubitemid 32037715)
41. Zent O, Hennig R. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine 23(5), 579-584 (2004). (Pubitemid 39473186)